Thomas Michael Roy, MD Internal Medicine - Pulmonary Disease Medicare: Not Enrolled in Medicare Practice Location: Corner Of Sidney And Lamont, 111-b, Mountain Home, TN 37614 Phone: 423-926-1171 |
Dr. Miguel Antonio Ossorio, M.D. Internal Medicine - Pulmonary Disease Medicare: Not Enrolled in Medicare Practice Location: James H.quillen Medical Center, Mountain Home, TN 37684 Phone: 423-926-1171 Fax: 423-979-3476 |
News Archive
Viruses that can target and destroy bacteria have the potential to be an effective strategy for tackling hard-to-treat bacterial infections. The development of such novel therapies is being accelerated in response to growing antibiotic resistance, says Dr David Harper at the Society for General Microbiology's Spring Conference in Dublin.
Scientists have determined the detailed structure of an essential piece of the telomerase enzyme, an important contributor to the vast majority of human cancers. Understanding the physical shape of the protein has led to a better understanding of how it acts to immortalize cells - and should help scientists design broadly effective cancer drugs.
BioMarin Pharmaceutical Inc. today announced an update on the Phase I/II trial for BMN 110 or N-acetylgalactosamine 6-sulfatase (GALNS), intended for the treatment of the lysosomal storage disorder Mucopolysaccharidosis Type IVA (MPS IVA), or Morquio A Syndrome. Preliminary clinical data from the first 24 weeks of the study (12 weeks at 0.1mg/kg and 12 weeks at 1.0 mg/kg) have been evaluated, and BioMarin plans to announce top-line results for the full 36-week study after completion of dosing at 2.0 mg/kg in the second quarter of 2010.
Document Storage Systems, Inc. (DSS) today announced that Spectron Corp. of Tulsa, OK has become its first distribution partner. Spectron will redistribute vxVistA, DSS' free and open source version of the VistA system and resell DSS' proprietary add-on products.
Researchers at the University of Oxford, in collaboration with colleagues from Hannover Medical School and Martin-Luther-University Halle-Wittenberg, have discovered the specific gene mutations that are required for the development of leukemia in children with Down's syndrome.
› Verified 7 days ago